reports
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Co...
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences BOSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that David Meeker, M.D., Chair, President and Chief Executive Officer, will participate in fireside chats at two upcoming investor conferences: Wells Fargo Healthcare Conference on Wednesday, September 3, 2025 at 9:30 a.m. ETMorgan Stanley Global Healthcare Conference on...
Geo Group Inc: 1 director
A director at Geo Group Inc sold 72,038 shares at 21.455USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanot...
Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity – U.S. Food and Drug Administration accepts sNDA for filing with priority review; sets PDUFA goal date of December 20, 2025 -- – European Medicines Agency accepts and validates submission for Type II variation MAA for setmelanotide to treat acquired hypothalamic obesity – – Company to host “Commercial Readiness for Acquired Hypothalamic Obesity,” event for investors and analysts on Wednesday, September 24, in Boston – BOSTON, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceutical...
- Dave Nicoski
- Ross LaDuke
GPN GLOBAL PAYMENTS INC.
VECO VEECO INSTRUMENTS INC.
RYN RAYONIER INC.
MTH MERITAGE HOMES CORPORATION
LEN LENNAR CORPORATION CLASS A
KWR QUAKER CHEMICAL CORPORATION
JCOM J2 GLOBAL INC.
CCS CENTURY COMMUNITIES INC.
BBY BEST BUY CO. INC.
AEO AMERICAN EAGLE OUTFITTERS INC.
KMR MIRAE
AMWD AMERICAN WOODMARK CORPORATION
CNA CNA FINANCIAL CORPORATION
FI FRANK'S INTERNATIONAL NV
HP HELMERICH & PAYNE INC.
MGM MGM RESORTS INTERNATIONAL
WFT.. WEATHERFORD INTERNATIONAL PLC
FND FLOOR & DECOR HOLDINGS INC. CLASS A
HOG HARLEY-DAVIDSON INC.
ARRY ARRAY TECHNOLOGIES
REYN REYNOLDS CONSUMER PRODUCTS
ARRAY Technologies Completes Acquisition of APA Solar
ARRAY Technologies Completes Acquisition of APA Solar Combined product portfolio positions ARRAY to deliver fully integrated tracker and engineered foundation solutions for the solar industry ALBUQUERQUE, N.M., Aug. 14, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products, software, and services for utility-scale solar energy projects, today announced the successful completion of its acquisition of APA Solar (“APA”), a premier solar racking and structural solutions provider. This strategic ...
ARRAY Technologies, Inc. to Participate in Upcoming Investor Conferenc...
ARRAY Technologies, Inc. to Participate in Upcoming Investor Conferences and Events ALBUQUERQUE, N.M., Aug. 12, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products, software and services, today announced its attendance at the following upcoming investor events: Citi’s 2025 Natural Resources Conference August 14, 2025 in Las VegasARRAY’s CFO, H. Keith Jennings, will host in-person investor meetings. Interested investors should contact their Citi sales representative. Barclays 39th Annual En...
- Wedbush Research
WLDN WILLDAN GROUP
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
KURA KURA ONCOLOGY INC.
EXPE EXPEDIA GROUP INC.
CXW CORECIVIC INC.
CTMX CYTOMX THERAPEUTICS INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
SKY SKYLINE CHAMPION CORPORATION
AAPL APPLE INC.
RCKT ROCKET PHARMACEUTICALS
HEAR TURTLE BEACH CORP.
STRO SUTRO BIOPHARMA
PINS PINTEREST INC. CLASS A
DDOG DATADOG INC CLASS A
ACET ADICET BIO INC
CRSR CORSAIR GAMING
PLTK PLAYTIKA HOLDING
TTD THE TRADE DESK
CCSI INC.
JANX CONSENSUS CLOUD SOLUTIONS INC
SOUN JANUX THERAPEUTICS INC
EWTX SOUNDHOUND AI INC
SKLZ EDGEWISE THERAPEUTICS INC
DNTH SKILLZ INC
NATL DIANTHUS THERAPEUTICS INC
OS NCR ATLEOS CORPORATION
ONESTREAM INC
- Jay McCanless
ARRAY Technologies, Inc. Reports Financial Results for the Second Quar...
ARRAY Technologies, Inc. Reports Financial Results for the Second Quarter 2025 Commercial excellence continues to deliver, year-to-date volume growth up 84% over 2024 2025 Second Quarter Highlights Revenue of $362.2 millionGross Margin of 26.8%Adjusted gross margin(1) of 27.8%Net income to common shareholders of $28.5 millionAdjusted EBITDA(1) of $63.6 millionNet income per basic and diluted share of $0.19Adjusted net income per diluted share(1) of $0.25Total executed contracts and awarded orders at June 30, 2025 were over $1.8 billion Inclusive of strategic descoping and reconfigu...
- Wedbush Research
VMW VMWARE INC. CLASS A
WDC WESTERN DIGITAL CORPORATION
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RNG RINGCENTRAL INC. CLASS A
RARE ULTRAGENYX PHARMACEUTICAL INC.
QLYS QUALYS INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
NRZ NEW RESIDENTIAL INVESTMENT CORP.
NCMI NATIONAL CINEMEDIA INC.
MU MICRON TECHNOLOGY INC.
INTC INTEL CORPORATION
IMAX IMAX CORPORATION
AXTI AXT INC.
AMC AMC ENTERTAINMENT HOLDINGS INC. CLASS A
SKY SKYLINE CHAMPION CORPORATION
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
EGHT 8X8 INC.
CVCO CAVCO INDUSTRIES INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
GOSS GOSSAMER BIO
SMCI SUPER MICRO COMPUTER
DAWN INC.
STX DAY ONE BIOPHARMACEUTICALS INC
ALIT SEAGATE TECHNOLOGY HLDGS PLC
RIVN FOLEY TRASIMENE ACQUISITION CORP
GFS RIVIAN AUTOMOTIVE INC
SYRE GLOBALFOUNDRIES INC
SPYRE THERAPEUTICS INC.
- Jay McCanless
ARRAY Technologies to Supply 100% Domestic Content Solar Trackers for ...
ARRAY Technologies to Supply 100% Domestic Content Solar Trackers for 200MW Indiana Solar Project ARRAY Embarks on Its Commitment to Provide 100% Domestic Content DuraTrack⁽ᴿ⁾ and OmniTrack™ Offerings for Customers ALBUQUERQUE, N.M., Aug. 05, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies (NASDAQ: ARRY) (“ARRAY” or the “Company”), a leading global provider of solar tracking technology products, software and services, today announced it will supply trackers for a 200 megawatt (MWac) solar project that meet 100% of the domestic content Assigned Cost Percentage (ACP) under the U.S. Treasury D...
Rhythm Pharmaceuticals Reports Second Quarter 2025 Financial Results a...
Rhythm Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Update -- Second quarter 2025 net product revenue from global sales of IMCIVREE® (setmelanotide) of $48.5 million -- -- U.S. and EU regulatory submissions for setmelanotide in acquired hypothalamic obesity on track to be completed in the third quarter of 2025 -- -- Bivamelagon Phase 2 trial met primary endpoint with statistically significant, clinically meaningful BMI reductions in patients with acquired hypothalamic obesity -- -- Raised approximately $189.2 million in net proceeds in upsized public offeri...
Palomar Holdings, Inc. Reports Second Quarter 2025 Results
Palomar Holdings, Inc. Reports Second Quarter 2025 Results LA JOLLA, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or “Company”) reported net income of $46.5 million, or $1.68 per diluted share, for the second quarter of 2025 compared to net income of $25.7 million, or $1.00 per diluted share, for the second quarter of 2024. Adjusted net income(1) was $48.5 million, or $1.76 per diluted share, for the second quarter of 2025 as compared to $32.0 million, or $1.25 per diluted share, for the second quarter of 2024. Second Quarter 2025 Highlights ...
- Wedbush Research
WDC WESTERN DIGITAL CORPORATION
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
NCMI NATIONAL CINEMEDIA INC.
MU MICRON TECHNOLOGY INC.
MNKD MANNKIND CORP.
KURA KURA ONCOLOGY INC.
INTC INTEL CORPORATION
CXW CORECIVIC INC.
CTMX CYTOMX THERAPEUTICS INC.
CNK CINEMARK HOLDINGS INC.
BMRN BIOMARIN PHARMACEUTICAL INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
AXTI AXT INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
NTLA INTELLIA THERAPEUTICS INC.
CVCO CAVCO INDUSTRIES INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
RCUS ARCUS BIOSCIENCES
HEAR TURTLE BEACH CORP.
SRRK SCHOLAR ROCK HOLDING CORPORATION
ARVN ARVINAS HOLDING
SMCI SUPER MICRO COMPUTER
RVMD INC.
CRSR REVOLUTION MEDICINES
PRAX CORSAIR GAMING
TVTX PRAXIS PRECISION MEDICINES
PLTK TRAVERE THERAPEUTICS INC
NUVB PLAYTIKA HOLDING
DAWN NUVATION BIO INC (A)
TNGX DAY ONE BIOPHARMACEUTICALS INC
STX TANGO THERAPEUTICS
GFS INC
SKLZ SEAGATE TECHNOLOGY HLDGS PLC
CBIO GLOBALFOUNDRIES INC
SKILLZ INC
CRESCENT BIOPHARMA INC.
- Jay McCanless
Palomar Holdings, Inc. Announces Second Quarter 2025 Financial Results...
Palomar Holdings, Inc. Announces Second Quarter 2025 Financial Results Release Date and Conference Call LA JOLLA, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Palomar Holdings, Inc. (NASDAQ: PLMR) (the “Company”) today announced that it will release its second quarter 2025 results after market close on Monday, August 4, 2025, and will host a conference call at 12:00 p.m. (Eastern Time) the following day, Tuesday, August 5, 2025. The conference call can be accessed live by dialing 1-877-423-9813 or for international callers, 1-201-689-8573, and requesting to be joined to the Palomar Second Q...
Rhythm Pharmaceuticals to Report Second Quarter 2025 Financial Results...
Rhythm Pharmaceuticals to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025 BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, August 5, 2025 to report its second quarter 2025 financial results and provide a corporate update. To access the live conference call, participants may register . W...
ARRAY Technologies, Inc. Announces Second Quarter 2025 Earnings Releas...
ARRAY Technologies, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call ALBUQUERQUE, N.M., July 17, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies, Inc. (the “Company” or “ARRAY”) (Nasdaq: ARRY), a global leader in utility-scale solar tracking, today announced that the Company will release its second quarter 2025 results after the market closes on Thursday, August 7, 2025, to be followed by a conference call at 5:00 p.m. (Eastern Time) that same day. The conference call can be accessed live over the phone by dialing (866)-682-6100 (domestic) or (862)-298-0702 (int...
- Abe Rimatzki
- Seth Basham
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.